earnings
confidence high
sentiment negative
materiality 0.70
Outset Medical Q3 revenue $29.4M (+3%); cuts FY 2025 revenue guidance to $115-120M
Outset Medical, Inc.
2025-Q3 EPS reported
-$4.37
revenue$90,602,000
- Net loss $17.8M vs $27.9M a year ago; non-GAAP net loss $12M vs $20.2M.
- Gross margin expanded to 39.4% (non-GAAP 39.9%) from 34.3% a year ago.
- FY 2025 revenue guidance reduced to $115-120M from prior $122-126M.
- Cash use improved to <$6M in Q3; total cash $182M at quarter end.
- Operating expenses declined 19% YoY to $27.4M; path to profitability focus.